Whole genome scanning as a cytogenetic tool in hematologic malignancies.
about
Institutional shared resources and translational cancer researchFISH and SNP-A karyotyping in myelodysplastic syndromes: improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q)Molecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise?SNPs Array Karyotyping in Non-Hodgkin LymphomaUse of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemiaMutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia.Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignanciesThe challenging world of cytopenias: distinguishing myelodysplastic syndromes from other disorders of marrow failureSNPs array karyotyping reveals a novel recurrent 20p13 amplification in primary myelofibrosis.Genome-wide Mapping of Copy Number Variations Using SNP Arrays.The Biology and Targeting of FLT3 in Pediatric Leukemia.Assessing karyotype precision by microarray-based comparative genomic hybridization in the myelodysplastic/myeloproliferative syndromesMutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia.Loss of the wild-type allele contributes to myeloid expansion and disease aggressiveness in FLT3/ITD knockin mice.Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide.Genomic evolution in Barrett's adenocarcinoma cells: critical roles of elevated hsRAD51, homologous recombination and Alu sequences in the genome.Statistical genetic issues for genome-wide association studiesLoss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasmsDiagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.Single nucleotide polymorphism arrays: a decade of biological, computational and technological advances.Polymorphisms in microRNA-related genes are associated with survival of patients with T-cell lymphoma.Gene expression profiling in MDS and AML: potential and future avenues.Pathogenesis and consequences of uniparental disomy in cancer.The Third Consensus Conference on the treatment of aplastic anemia.Optimizing management of myelodysplastic syndromes post-allogeneic transplantation.Molecular diagnosis of leukemia.Array comparative genomic hybridization in pediatric acute leukemias.Recent advances in understanding the molecular pathogenesis of myelodysplastic syndromes.I walk the line: how to tell MDS from other bone marrow failure conditions.Single-nucleotide polymorphism-array improves detection rate of genomic alterations in core-binding factor leukemia.A genome-wide single-nucleotide polymorphism-array can improve the prognostic stratification of the core binding factor acute myeloid leukemia.Genome-wide high density single-nucleotide polymorphism array-based karyotyping improves detection of clonal aberrations including der(9) deletion, but does not predict treatment outcomes after imatinib therapy in chronic myeloid leukemia.Evaluation of chronic lymphocytic leukemia by oligonucleotide-based microarray analysis uncovers novel aberrations not detected by FISH or cytogenetic analysis.What Is the Clinical Utility of Repeat SNP Array Testing in the Follow-up of Myeloid Neoplasms?: A Retrospective Analysis of 44 Patients With Serial SNP Arrays.The vanguard has arrived in the clinical laboratory: array-based karyotyping for prognostic markers in chronic lymphocytic leukemia.TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p.Cryptic chromosome abnormalities in a patient with mixed phenotype acute leukemia250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies.Metaphase cytogenetics and single nucleotide polymorphism arrays in myeloid malignancies.
P2860
Q24288943-F629BC1C-2F1F-49E2-AE24-EAA72735D280Q24644421-B00EB0BD-5E8C-41AE-A27B-FA72C14E52E2Q26801573-8824F7B2-8BC2-4C53-AEAD-11A8988E2058Q28085444-9A4A2117-8482-429B-BCB1-12B06AA2CDC2Q28390558-4751216E-3319-4DA1-AEBB-A486903672F1Q33722741-6281B6AA-BFD4-482B-8054-79EAC1752ADCQ33788643-CECE2CFC-DF2B-4448-94AA-326E4C0CD8A6Q33829778-C9A67204-C0BB-439D-8FCB-24770F2D6709Q34081581-DAD7794D-9D4C-412A-806E-E4BCC050459BQ34139304-0B2B02FE-F55A-45CE-97A2-71D3E5D21222Q34229555-5DA6954A-54C3-48A7-8986-C5EA35AB4EE6Q34400180-BB94A7B4-3854-4145-8D16-5429B9F52A94Q34578265-5E031443-2F3D-4374-86A6-061C1F4ABEFCQ35030952-7E32DD8A-691D-4262-802C-A16FBF546C61Q35525611-7A46125A-09E1-4823-9499-6FED71683BF2Q35881223-484F743B-D05D-4AFF-B956-A3A277911D0FQ36120783-54A2805D-834F-4BDA-8F17-B9C04A999208Q36391069-789A9A35-521C-4D40-AE72-D24187A7D2AAQ37262428-956AE72E-F95A-4488-88FC-E5E39CCF95CFQ37263146-A1B96D66-6DD6-4913-9250-0E2CC4FAD760Q37273694-A5C49993-EC37-4422-AB5D-53383C992782Q37644547-4CF76943-1C55-4D04-B219-52303201BAA6Q37858877-AB8EA36F-ADCF-441D-8426-BE5805073A37Q37868831-1FE76675-E29C-4386-AE0B-FBA98542F718Q37880645-D07A7465-99EA-4A55-9018-3F296B0D970FQ37955235-EEF0D429-D25C-48F3-B87D-212FC0D02C30Q38018998-DC824136-6BDF-4325-9963-D89B29FB37FFQ38113815-4673BCB0-5128-4487-9465-C5797BEB8087Q38122703-88E605F7-284A-4931-B7FB-52840078B167Q38235622-86EBA097-526E-4C6A-A1AC-126439C9CD9BQ38315894-E1A5714D-0A54-498A-8E2E-30ED719DCDD4Q38459577-D0BAC3C4-66E3-4AD6-9210-6A9E567FE758Q38476431-3A002C55-2883-40CF-8963-917BE85D1CABQ39686496-8CC39E84-C2DC-4C55-8E56-FD72D2330800Q40250091-50D2C40F-F806-4FFE-8FB1-57880896F050Q40609808-BCF9B35F-07F2-4EF2-80A0-1BD6146AB0E4Q41813518-3398E683-0BCD-4077-AFD2-F337A7D3EE95Q41924078-5412251B-4AC3-48F9-BEAF-8464113A36D7Q43078973-DF50CB0C-B117-4E8D-AFC3-0F0B9D9C826DQ43212949-CDE91A63-0BFC-4F54-BE92-20E05E1FB88D
P2860
Whole genome scanning as a cytogenetic tool in hematologic malignancies.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Whole genome scanning as a cytogenetic tool in hematologic malignancies.
@en
type
label
Whole genome scanning as a cytogenetic tool in hematologic malignancies.
@en
prefLabel
Whole genome scanning as a cytogenetic tool in hematologic malignancies.
@en
P2860
P1433
P1476
Whole genome scanning as a cytogenetic tool in hematologic malignancies.
@en
P2093
Ghulam J Mufti
Jaroslaw P Maciejewski
P2860
P304
P356
10.1182/BLOOD-2008-02-130435
P407
P577
2008-05-27T00:00:00Z